✦ LIBER ✦

PGI5 COST-EFFECTIVENESS OF NATALIZUMAB IN CROHN'S DISEASE PATIENTS WHO HAVE FAILED ANTI-TNF ALPHA THERAPY

✍ Scribed by S Panjabi; T Niecko; SL Hass; L Lacey; MD Spencer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1126 Cost-Effectiveness of Natalizumab

✍ Sands, Bruce E.; Wolf, Douglas C.; Panjabi, Sumeet; Niecko, Timothy; Hass, Steve 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Cost-Effectiveness of Third-Line Anti-TN

✍ Ananthakrishnan, Ashwin N. ;Hur, Chin ;Korzenik, Joshua R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P.06.12 NUTRITIONAL EFFECTS OF ANTI-TNF-

✍ S. Mazzuoli; I. Addante; S. Fragnan; N. Regano; M. Rizzi; G. Leogrande; A. Di Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P530 Effectiveness of anti-TNF drugs in

✍ R-Grau, M.; Chaparro, M.; Mesonero, F.; Barreiro-de Acosta, M.; Castro, L.; Vera 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 70 KB

OC.11.5 ASSOCIATION OF THALIDOMIDE WITH

✍ Scribano, M.L.; Monterubbianesi, R.; Cantoro, L.; Kohn, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Cost-Effectiveness Analysis of Biologica

✍ Ryazhenov, V.V.; Emchenko, I.V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB